George A. Scangos - Director at Vir Biotechnology, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by George A. Scangos since 05 Sep 2025

Reported holdings for George A. Scangos in Vir Biotechnology, Inc.

Form 4 holding Director

Vir Biotechnology, Inc.

Security class
Common Stock
Shares / value
698,239
Estimated value
$6,600,733
Report date
24 Feb 2025
Price
$9.45
Ownership
Direct
Form 4 holding Director

Vir Biotechnology, Inc.

Security class
Common Stock
Shares / value
179,930
Estimated value
$1,700,950
Report date
24 Feb 2025
Price
$9.45
Ownership
Indirect
Form 4 holding Director

Vir Biotechnology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
16,000
Estimated value
$24,480
Report date
30 May 2024
Price
$1.53
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for George A. Scangos in Vir Biotechnology, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .